ARC Consulting, Perth, W Australia 6050, Australia.
J Diabetes Complications. 2010 Mar-Apr;24(2):129-41. doi: 10.1016/j.jdiacomp.2009.01.002. Epub 2009 Feb 20.
To review the recent literature relating to the role of self-monitoring of blood glucose (SMBG) and glycemic control.
Medline and EMBASE databases were searched between 1996 and June 2008 using terms that included diabetes mellitus, self-care, and blood glucose self monitoring. Both experimental and nonexperimental studies with HbA(1c) as an outcome measure were included. A meta-analysis was performed on randomized controlled trials (RCTs) in type 2 diabetes which met the inclusion criteria.
From 1102 relevant papers, 34 original containing 38 separate studies were identified as being published between 2000 and June 2008. There were 23 studies of type 2 diabetes and, of these, 13 were nonexperimental and 10 experimental, including six RCTs. The results of five of these RCTs in non-insulin-treated type 2 diabetic patients were combined in a meta-analysis with two earlier RCTs which yielded a significant pooled SMBG-related decrease in HbA(1c) of -0.22 (95% CI -0.34% to -0.11%).
The present meta-analysis showed an SMBG-related HbA(1c) reduction in non-insulin-treated type 2 diabetes patients that was similar to that in previous systematic reviews but in a substantially larger patient sample. This finding is consistent with most observational studies of similarly treated patients.
回顾近期有关自我血糖监测 (SMBG) 和血糖控制作用的文献。
检索 Medline 和 EMBASE 数据库,检索时间为 1996 年至 2008 年 6 月,使用的术语包括糖尿病、自我护理和血糖自我监测。纳入的研究均以 HbA(1c) 为结局指标,包括实验和非实验研究。对符合纳入标准的 2 型糖尿病随机对照试验 (RCT) 进行荟萃分析。
从 1102 篇相关文献中,确定了 34 篇原始文献,其中包含 38 项独立研究,这些文献发表于 2000 年至 2008 年 6 月期间。有 23 项关于 2 型糖尿病的研究,其中 13 项是非实验性的,10 项是实验性的,包括 6 项 RCT。对 6 项非胰岛素治疗的 2 型糖尿病患者的 RCT 中的 5 项结果进行了荟萃分析,与之前的 2 项 RCT 结果合并,HbA(1c) 有显著的 SMBG 相关降低,为 -0.22(95%CI-0.34%至-0.11%)。
本荟萃分析显示,非胰岛素治疗的 2 型糖尿病患者的 SMBG 相关 HbA(1c) 降低与之前的系统评价相似,但纳入的患者样本量更大。这一发现与大多数对类似患者进行的观察性研究一致。